Transcorneal electrical stimulation for the treatment of retinitis pigmentosa: a multicentre safety study of the Okustim® system

niversity of Oxford (UK)0 个研究点目标入组 14 人开始时间: 2013年5月17日最近更新: 2019年9月9日

适应症

试验速览

•1. Male or female participants of 18 years of age or more
•2. Participants with retinitis pigmentosa (diagnosed by an ophthalmologist)
•3. Adult participants who have capacity
•4. Visual acuity greater or equal to 0.02
•5. Participants, their caregiver or a family member should have adequate motor skills to apply electrodes
•6. Participants must be able to give consent and undertake a medical evaluation to assess whether they can participate in the whole study according to the protocol
•7. Participant willing to allow their GP and consultant, if appropriate, to be notified of participation in the study.

•1. Diabetic retinopathy
•2. Neovascularisation of any origin
•3. Previous arterial or venous occlusion
•4. Previous retinal detachment
•5. Silicone oil tamponade
•6. Dry or exudative age-related macular degeneration
•7. Macular oedema
•8. Any form of glaucoma
•9. Any form of corneal disease, which impairs visual acuity
•10. Systemic disease, which may be difficult to control or manage, and may affect normal study schedule
•11. Mental Illness related to bipolar affective disorders, schizoid-affective disorders and all forms of dementia
•12. Simultaneous participation in another interventional study or previous interventions, where effects may still persist
•13. Female participants who are pregnant, lactating or planning pregnancy during the course of the study

发起方

niversity of Oxford (UK)